Clinical management of disturbances of calcium and phosphate metabolism in dialysis patients
نویسندگان
چکیده
Management of chronic kidney disease-mineral bone disorder can be difficult in renal patients. This review aims to explain why the control of disturbed calcium, phosphate, parathyroid hormone and vitamin D metabolism is important in dialysis patients. The methods available to regulate these parameters include diet, phosphate binders, dialysate calcium, native vitamin D, active vitamin D derivatives and calcimimetics. An overview of current treatment guidelines will be discussed.
منابع مشابه
The need for better control of secondary hyperparathyroidism.
Secondary hyperparathyroidism (SHPT), a frequent complication of chronic kidney disease, develops in response to an imbalance in the serum levels of calcium, phosphorus and vitamin D as a result of altered metabolism. Raised serum levels of parathyroid hormone (PTH) and calcium-phosphorus product have a major effect on morbidity and mortality in dialysis patients. The new Kidney Disease Outcome...
متن کاملنقش هورمون پاراتیرویید بر قامت بیماران مبتلا به بتاتالاسمی ماژور
The Role of Parathyroid Hormone on Stature in Major Beta-Thalassemic Patients GR. Moshtaghi Kashanian PhD 1 , A. Ahmadi MD2, MM. Hayat Bakhsh MD3 1- Assistant professor, Dept. of Biochemistry, Faculty of Medicine, University of Medical Sciences, Kerman, Iran 2- Professor of Pediaterics, University of Medical Sciences, Kerman, Iran 3- Assistant professor of Internal Medicine, Facul...
متن کاملControl of mineral metabolism and bone disease in haemodialysis patients: which optimal targets?
BACKGROUND There is a high drug treatment burden on patients receiving long-term dialysis therapy. Abnormalities of calcium and phosphate metabolism are associated with increased mortality, and attempts to correct these disturbances may improve survival. METHODS We prospectively evaluated the targets of the currently used Kidney Disease: Improving Global Outcomes (KDIGO) guidelines in 8377 pr...
متن کاملLong term effects on mineral and bone metabolism by low versus standard calcium dialysate in peritoneal dialysis: a meta-analysis.
BACKGROUND Low calcium dialysate with 1.25 mmol/l calcium concentration has been proposed to replace standard calcium dialysate in peritoneal dialysis patients taking calcium-containing phosphate binder to prevent hypercalcaemia. We conducted a meta-analysis to evaluate long term effects on mineral and bone metabolism by low versus standard calcium dialysate in peritoneal dialysis. METHOD Cli...
متن کاملPractical use of sevelamer in chronic kidney disease patients on dialysis in People’s Republic of China
Hyperphosphatemia is a common complication of dialysis patients. Only 38.5% of Chinese dialysis patients met the Kidney Disease Outcomes Quality Initiative defined targets for serum phosphate. Sevelamer is a high molecular weight cationic hydrogel polymer that prevents absorption of dietary phosphate by binding it in the gastrointestinal tract. In Chinese trials, it was confirmed that sevelamer...
متن کامل